Table 3 |
|||||||
|
High prevalence of metabolic syndrome in patients with rheumatic diseases |
|||||||
|
Metabolic syndrome prevalence, percentage |
|||||||
|
|
|||||||
|
Number |
Mean age, years |
Women, percentage |
NCEP |
WHO |
NCEP |
WHO |
|
|
|
|||||||
|
Rheumatoid arthritis (RA) |
Control |
||||||
|
|
|
||||||
|
Karvounaris, et al. [62] |
200 |
63 |
74 |
44 |
- |
41 |
- |
|
Chung, et al. [63] |
|||||||
|
Early RA |
88 |
51 |
64 |
30 |
31 |
22 |
- |
|
Established RA |
66 |
59 |
73 |
42 |
42 |
||
|
Dessein, et al. [61] |
74 |
56 |
86 |
- |
19 |
- |
- |
|
|
|
||||||
|
Systemic lupus erythematosus |
Control |
||||||
|
|
|
||||||
|
Chung, et al. [67] |
102 |
40 |
91 |
29 |
32 |
20 |
11 |
|
Magadmi, et al. [66] |
44 |
51 |
100 |
18 |
- |
- |
- |
|
|
|
||||||
|
Ankylosing spondylitis |
Control |
||||||
|
|
|
||||||
|
Malesci, et al. [68] |
24 |
51 |
12 |
46 |
- |
11 |
- |
|
|
|||||||
|
NCEP, National Cholesterol Education Program; WHO, World Health Organization. |
|||||||
|
Sidiropoulos et al. Arthritis Research & Therapy 2008 10:207 doi:10.1186/ar2397 |
|||||||